Stocktoria

Apyx Medical Corp APYX

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1983-07-22 · LEI

Apyx Medical Corp statistics & valuation

Market cap$188.4M
P / S3.6×
P / B12.7×
Net margin-21.2%
Return on equity-75.6%
FCF margin-17.2%
Net debt$5.8M
Enterprise value USD$194.2M
Earnings yield EBIT/EV-3.3%
Return on capital-11.7%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-131.00% -49.50% 375.90% -69.80% -42.90% -31.30% -52.10% -35.70% -48.80% -21.20% 2016201720182019202020212022202320242025
Gross margin (%)
58.00% 68.00% 64.90% 67.60% 63.20% 69.30% 65.40% 64.50% 61.00% 62.50% 2016201720182019202020212022202320242025
Operating margin (%)
-129.20% -135.70% -85.60% -73.90% -72.50% -29.80% -52.90% -33.00% -39.20% -12.20% 2016201720182019202020212022202320242025
Return on equity (%)
-44.00% -23.00% 71.90% -27.70% -18.60% -28.10% -61.30% -69.50% -163.70% -75.60% 2016201720182019202020212022202320242025
Shares outstanding
30.9M 32.9M 34.4M 34.2M 34.3M 34.4M 34.6M 34.6M 37.8M 41.8M 2016201720182019202020212022202320242025
Net debt ($)
-$11.5M -$7.3M -$16.6M -$10.2M -$10.5M $5.8M $5.8M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-32.90% -16.30% 65.40% -23.30% -16.10% -22.10% -44.80% -23.60% -36.20% -16.80% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-35.40% -42.30% -127.30% -70.00% -60.10% -23.00% -47.80% -11.00% -39.00% -17.20% 2016201720182019202020212022202320242025
Debt / equity (×)
0.11× 0.12× 0.00× 0.00× 1.23× 2.62× 2.53× 2016201720182019202020212022202320242025
EPS ($)
-$0.15 -$0.17 $1.83 -$0.58 -$0.35 -$0.44 -$0.67 -$0.54 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin62.5%61.0%64.5%65.4%69.3%63.2%67.6%64.9%68.0%58.0%
Operating margin-12.2%-39.2%-33.0%-52.9%-29.8%-72.5%-73.9%-85.6%-135.7%-129.2%
Net margin-21.2%-48.8%-35.7%-52.1%-31.3%-42.9%-69.8%375.9%-49.5%-131.0%
FCF margin-17.2%-39.0%-11.0%-47.8%-23.0%-60.1%-70.0%-127.3%-42.3%-35.4%
Return on assets-16.8%-36.2%-23.6%-44.8%-22.1%-16.1%-23.3%65.4%-16.3%-32.9%
Return on equity-75.6%-163.7%-69.5%-61.3%-28.1%-18.6%-27.7%71.9%-23.0%-44.0%
Debt / equity2.53×2.62×1.23×0.00×———0.00×0.12×0.11×
Current ratio5.005.265.523.634.607.226.2310.433.775.03

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.